Posts Tagged ‘2025-2026’

Damian Chase-Begay, PhD, MS | February 17, 2026 : The He Pikinga Waiora (HPW) Framework offers a culturally-centered, community-engaged implementation model developed in Indigenous contexts to guide health promotion and chronic disease prevention efforts. First, this presentation will provide a concise overview of the framework’s origin, key principles (including cultural-centeredness, community engagement, systems thinking, and…

Lydia Kwak, PhD, Andreas Rödlund, PhD | February 10, 2026 : A key priority in implementation science is to understand the mechanisms of implementation strategies, describing how and why they function. Yet, the knowledge about mechanisms of implementation strategies is scarce, and experimental studies exploring these mechanisms are still few. This presentation will share findings…

Guillaume Fontaine, PhD, MSc, RN | January 27, 2026 : This presentation will outline the findings of an umbrella review cataloguing the current universe of implementation science theories, models, and frameworks (TMFs), describing their purposes, structures, analytic levels, and historical trends. From 9,276 records, 44 reviews (2002–2024) were included, identifying 614 unique TMFs published 1939–2022…

Erika Crable, PhD, MPH, Lindsey Zimmerman, PhD | January 20, 2026 : Starting substance use disorder (SUD) treatment reduces odds of overdose and death, making the period after diagnosis a critical window for intervention. Patients who effectively engage in SUD treatment early are more likely to be retained in treatment for at least six months.…

Yuvaram Reddy, MBBS, MPH | January 13, 2026 : Home-based care for patients with complex chronic diseases can be challenging to administer, in part because these disease states, such as home dialysis for kidney failure, require complex sociotechnical interventions over a long duration of time. The complex nature of these treatments also makes it difficult…

Alice Zhang, MD, MPH | January 6, 2026 : Harm reduction-focused vending machines, delivering naloxone, fentanyl test strips, and other public health items, represent a potential non-stigmatizing, low-barrier approach to harm reduction that may increase access and engagement with underserved populations, reduce overdoses and related public health conditions, and health disparities in substance use disorder.…

Wayne Kepner, PhD, MPH | November 18 2025 : A significant barrier to addressing the opioid crisis is the “false dichotomy” between two of our most effective strategies; medications for opioid use disorder (MOUD) and 12-step mutual help groups (MHG). MOUD is the most effective pharmacological treatment to reduce mortality, while MHGs provide invaluable access…

Niranjan S. Karnik, M.D., Ph.D. | November 4, 2025 : Translating data science innovations into real-world clinical impact remains a critical challenge in healthcare. This talk presents the story of C-DOSETaP (Chicago Data-Driven OUD Screening, Engagement, Treatment and Prevention) project, a NIDA-funded initiative under the Helping to End Addiction Long-term Data to Action (HD2A) program.…

Hannah Cheng, MS and Todd Wagner, PhD | October 21, 2025 : This presentation highlights practical and innovative approaches to economic evaluations in implementation endeavors. Part I provides an overview of Delivering Implementation Strategies Cost (DISCo), a pragmatic micro-costing tool that separates delivery and participation costs while outlining practical considerations for measuring implementation costs. Part…

Sandra Japuntich, PhD | October 28, 2025 : Hybrid implementation-effectiveness trials hold tremendous promise to speed implementation by collecting data necessary for implementation whilst conducting effectiveness data. This presentation will review hybrid clinical trial design and present outcomes from two hybrid implementation-effectiveness trials of smoking cessation treatments. Insights and experiences will be shared about the…